Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Vical patents

Patents where

Current Assignee

Name

‌

Vical

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8128938 Influenza virus vaccine composition and methods of use	Patent 8128938 was granted and assigned to Vical on March, 2012 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	8128938	March 6, 2012
‌ US Patent 7410795 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection	Patent 7410795 was granted and assigned to Vical on August, 2008 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	7410795	August 12, 2008
‌ US Patent 7888112 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection	Patent 7888112 was granted and assigned to Vical on February, 2011 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	7888112	February 15, 2011
‌ US Patent 9180162 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection	Patent 9180162 was granted and assigned to Vical on November, 2015 by the United States Patent and Trademark Office.	‌ Vical	‌ Vical	United States Patent and Trademark Office	9180162	November 10, 2015
‌ US Patent 7537768 Influenza virus vaccine composition and methods of use	Patent 7537768 was granted and assigned to Vical on May, 2009 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	7537768	May 26, 2009
‌ US Patent 7785603 Influenza virus vaccine composition and methods of use	Patent 7785603 was granted and assigned to Vical on August, 2010 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	7785603	August 31, 2010
‌ US Patent 7268120 Methods for treating cancer using cytokine-expressing polynucleotides	Patent 7268120 was granted and assigned to Vical on September, 2007 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	7268120	September 11, 2007
‌ US Patent 8673317 Codon-optimized polynucleotide-based vaccines against human	Patent 8673317 was granted and assigned to Vical on March, 2014 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	8673317	March 18, 2014
‌ US Patent 8080642 Severe acute respiratory syndrome DNA compositions and methods of use	Patent 8080642 was granted and assigned to Vical on December, 2011 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	8080642	December 20, 2011
‌ US Patent 7381422 Method for producing sterile polynucleotide based medicaments	Patent 7381422 was granted and assigned to Vical on June, 2008 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	7381422	June 3, 2008
‌ US Patent 8435557 Method for producing sterile polynucleotide based medicaments	Patent 8435557 was granted and assigned to Vical on May, 2013 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	8435557	May 7, 2013
‌ US Patent 6875748 Compositions and methods for in vivo delivery of polynucleotide-based therapeutics	Patent 6875748 was granted and assigned to Vical on April, 2005 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	6875748	April 5, 2005
‌ US Patent 7521187 Method for freeze-drying nucleic acid/block copolymer/cationic surfactant complexes	Patent 7521187 was granted and assigned to Vical on April, 2009 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	7521187	April 21, 2009
‌ US Patent 9102950 Compositions and methods for enhancing immune responses to vaccines	Patent 9102950 was granted and assigned to Vical on August, 2015 by the United States Patent and Trademark Office.	‌ Vical	‌ Vical	United States Patent and Trademark Office	9102950	August 11, 2015
‌ US Patent 7105574 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines	Patent 7105574 was granted and assigned to Vical on September, 2006 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	7105574	September 12, 2006
‌ US Patent 8821890 Influenza virus vaccine composition and methods of use	Patent 8821890 was granted and assigned to Vical on September, 2014 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	8821890	September 2, 2014
‌ US Patent 8278093 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection	Patent 8278093 was granted and assigned to Vical on October, 2012 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	8278093	October 2, 2012
‌ US Patent 7700350 Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates	Patent 7700350 was granted and assigned to Vical on April, 2010 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	7700350	April 20, 2010
‌ US Patent 8840903 Compositions and methods for vaccinating against HSV-2	Patent 8840903 was granted and assigned to Vical on September, 2014 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	8840903	September 23, 2014
‌ US Patent 7582613 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines	Patent 7582613 was granted and assigned to Vical on September, 2009 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	7582613	September 1, 2009
‌ US Patent 7470675 Methods for treating cancer using interferon-ω-expressing polynucleotides	Patent 7470675 was granted and assigned to Vical on December, 2008 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	7470675	December 30, 2008
‌ US Patent 8999345 Compositions and methods for enhancing immune responses to vaccines	Patent 8999345 was granted and assigned to Vical on April, 2015 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	8999345	April 7, 2015
‌ US Patent 8415317 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines	Patent 8415317 was granted and assigned to Vical on April, 2013 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	8415317	April 9, 2013
‌ US Patent 8541628 Complex cationic lipids having quaternary nitrogens therein	Patent 8541628 was granted and assigned to Vical on September, 2013 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	8541628	September 24, 2013
‌ US Patent 6867195 Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected	Patent 6867195 was granted and assigned to Vical on March, 2005 by the United States Patent and Trademark Office.		‌ Vical	United States Patent and Trademark Office	6867195	March 15, 2005

Results per page:

25 results

0 selected

25 results

0 selected